FERRANTI, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 1162
EU - Europa 517
AS - Asia 174
SA - Sud America 7
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1867
Nazione #
US - Stati Uniti d'America 1137
IT - Italia 146
UA - Ucraina 134
IN - India 101
SE - Svezia 89
CN - Cina 73
FI - Finlandia 55
GB - Regno Unito 28
CA - Canada 25
AT - Austria 22
DE - Germania 17
BE - Belgio 14
AR - Argentina 6
TG - Togo 5
RO - Romania 3
GR - Grecia 2
NL - Olanda 2
RU - Federazione Russa 2
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
PT - Portogallo 1
Totale 1867
Città #
Chandler 189
Fairfield 98
Woodbridge 63
Princeton 56
Ann Arbor 55
Plano 54
Wilmington 54
Beijing 52
Rome 51
Dearborn 47
Jacksonville 46
Ashburn 36
Des Moines 36
Houston 35
Seattle 32
Boston 31
Cambridge 30
Millbury 22
Vienna 17
Brussels 14
Toronto 13
Bremen 12
San Paolo di Civitate 12
San Diego 11
Andover 8
Southend 8
Auburn Hills 7
Lawrence 7
Boardman 6
Federal 6
Fremont 6
Norwalk 6
Formello 5
Kunming 5
Lomé 5
Alexandria 4
Hefei 4
Los Angeles 4
Falls Church 3
Florence 3
Bologna 2
Caserta 2
Frosinone 2
Jinan 2
Montréal 2
Quzhou 2
Redmond 2
San Mateo 2
Udine 2
Venezia 2
Verona 2
Angri 1
Buffalo 1
Capodrise 1
Changsha 1
Coominya 1
Cutrofiano 1
Ercolano 1
Flushing 1
Fuzhou 1
Genivolta 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Jiaxing 1
Langfang 1
Las Vegas 1
Laurel 1
Leipzig 1
Marina Di Gioiosa Ionica 1
Milan 1
Nanjing 1
Napoli 1
Nocera Inferiore 1
Ottawa 1
Palermo 1
Philadelphia 1
Phoenix 1
Pisa 1
Pomezia 1
Portland 1
Provo 1
Redwood City 1
Reggio Emilia 1
San Francisco 1
Secaucus 1
Seelze 1
Thiene 1
Trumbull 1
Valencia 1
Viterbo 1
Willowdale 1
Totale 1216
Nome #
Studio delle sindromi mielodisplastiche in citometria a flusso a 10 colori 90
Activated and "memory" phenotype of circulating T lymphocytes in intrauterine life 66
Valuation of MCP-1 and VEGF Chemokines In Serum of Patients with AL Amyloidosis 61
Clonal evolution in Philadelphia chromosome negative cells following successful treatment with imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome 60
una rete di laboratori ed ospedali per migliorare la qualità delle prestazioni sanitarie in italia.esperienza dei centri gimema 56
Duplication 3p and cyclopia. 55
Diagnosi prenatale non invasiva 54
CITOGENETICA CONVENZIONALE E MOLECOLARE SU 100 PAZIENTI CON LEUCEMIA LINFATICA CRONICA 54
Microdelezione del cromosoma Y in soggetti con oligo/azoospermia idiopatica 52
Heart Function In Systemic and Localized AL Amyloidosis: Role of NT-ProBNP and MPC-1 49
IL6 and IL10 activity in patients with carotid artery stenting (CAS) 49
IL-4 and IL-1 Serum Levels In Systemic and Localized Amyloidosis 49
MR-proANP and MCP-1 as effective biomarkers of cardiac and microvascular inflammatory impairment in systemic AL amyloidosis patients treated with MEL-DEX association. 47
Prenatal diagnosis of terminal deletion 1 (q42) 46
Osteocalcin and free light chain levels in amyloidosis 45
TH1/TH2 balance in a patient with amyotrophic lateral sclerosis (ALS) 39
NT-ProBNP and VEGF Serum Evaluation In AL Amyloidosis 39
Diagnosi prenatale non invasiva: isolamento di eritrociti nucleati fetali da sangue materno mediante micromanipolazione. 38
Cyrculating levels of vascular endothelial growth factor (VEGF) in patients with carotid artery stenting (CAS) 37
Diagnosi differenziale ecografica delle anomalie della regione nucale nel primo e nel secondo trimestre di gravidanza 36
First-trimester prenatal diagnosis of homozygous (14;21) translocation in a fetus with 44 chromosomes. 36
Fetal cells in maternal circulation 35
Fetal stem cell culture characterization in maternal blood for non invasive prenatal diagnosis 33
Valutazione di markers tumorali nel liquido cefalorachidiano (CSF) 33
Prenatal sex determination by DNA amplification from maternal serum 32
Identificazione di mutazioni nel gene hMRE11 in pazienti ATLD con Atassia senza Telangectasia 32
Caratterizazione di cellule emopoietiche fetali presenti nel circolo materno per una diagnosi prenatale non invasiva. 32
CYSTATIN C, B2-MICROGLOBULIN AND ALKALINE PHOSPHATASE SERUM LEVELS IN AL AMYLOIDOSIS 32
Correlation between serum levels of free light chain and circulating cytokines in a patient with AL cardiac amyloidosis 31
Mid-region pro-adrenomedullin (MR-PROADM) and homocysteine serum evaluation in HIV infection. 30
Fetal stem cells in maternal blood for non-invasive prenatal diagnosis. 30
MCP-1 and VGEF markers in the evaluation of systemic AL amyloidosis response to Upfront Melphalan-Dexamethasone Association. 29
FISH-MLL abnormalities in patients with acute myeloblastic leukemia and association with FLT3 and Mll internal duplication 29
Development of non invasive fetal DNA diagnosis from maternal blood by micromanipulation 28
DOSAGGIO DELLE MOLECOLE DI ADESIONE IN PAZIENTI CON CRIOGLOBULINEMIA 28
Renal function improvement evaluated by cystatin-C serum levels in patients with systemic AL amyloidosis treated with MEL-DEX association 27
Riflessioni sui trattamenti per l'infertilità e la possibile insorgenza di carcinomi ovarici 25
Use of the Troponin-I (cTn-I): an experience of one year 25
Clinical role of IL-6 and IL-1B in IgG and IgA multiple myeloma 25
Constitutional trisomy 8 in myelodysplstic syndromes and acute myeloid leukemia.Citogenetic findings in five patients 24
Dosaggio in diagnostica sierologica delle catene leggere libere nell’infezione sostenuta dal virus HIV 24
NGF receptor expression on uncultured amniotic fluid cells and NGF levels in amniotic fluid in 3 cases of anencephaly. 23
DIFFERENCE IN SERUM CYTOKINES PATTERN BETWEEN SYSTEMIC AND LOCALIZED AL AMYLOIDOSIS 23
Variation of the principal electrolytes in cerebrospinal fluid(CSF) and serum of patients with multiple sclerosis 22
Migrazione atipica di una componente monoclonale (CM) in regione alfa-2 rilevata mediante elettroforesi capillare (CE) in una paziente con mieloma multiplo asintomatico 22
MULTIPLE MYELOMA AND MGUS: A SERUM EVALUATION OF PCT, MR-PROAMD AND MR PROANP 22
TH1 and TH2 cells in multiple myeloma 20
Interference of medium contrast in serum capillary electrophoresis: a case-report 20
Valutazione sierologica delle catene leggere libere kappa e lambda in soggetti con infezione da virus HCV e crioglobulinemia di tipo II e III 20
MR-PROADM as marker of vascular damage reversibility in AL amyloidosis patients. 19
SERUM LEVELS OF MR-PROANP IN HIV AND HCV PATIENTS WITHOUT CRYOGLOBULINEMIA 18
MR-ProANP: A POSSIBLE ADDITIONAL CARDIAC MARKER IN AL AMYLOIDOSIS 18
Non invasive genetic prenatal diagnosis from maternal blood using stem cells. 17
THE SERUM LEVELS OF MR-proANP IN PATIENTS HCV POSITIVE WITH AND WITHOUT CRYOGLOBULINEMIA 12
The role of high-sensitivity C-reactive protein (HS-CRP) and mid-region pro-adrenomedullin (MR-PROADM) in HIV infect patients 3
Totale 1901
Categoria #
all - tutte 3212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20183 0000 00 00 0003
2018/2019150 135444 21 26 2292814
2019/2020399 586226 2774 5743 2737348
2020/2021134 241769 220 418 61882
2021/2022403 425268 645 347 234648104
2022/2023586 107523980 7492 925 747270
Totale 1901